Cure My Disease

Don't miss your cure!

 Log in / Sign up

Letting kids set their own therapy goals: a game changer?

NCT ID NCT05017363

Recruiting now Knowledge-focused Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a child-focused goal-setting method called ENGAGE helps children with neurodevelopmental disabilities do better in therapy. About 96 kids aged 5-12 and their therapists will be split into two groups: one using ENGAGE and one using usual care. Researchers will measure improvements in goal performance, daily functioning, and quality of life, and also check if the approach saves time and money.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ENGAGE goal-setting approach (a procedure involving goal-setting tools and strategies)
What this could lead to
If successful, this could show that involving children in setting their own therapy goals leads to better outcomes and more efficient use of rehabilitation services.
What could go wrong
This is a small, early-stage study with only 96 children, so results may not apply to all settings. The intervention is a behavioral procedure, not a drug, so effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEURODEVELOPMENTAL DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neurodevelopmental disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEURODEVELOPMENTAL DISORDERS

Contacts and locations

Locations

  • University of Alberta

    RECRUITING

    Edmonton, Alberta, T6G 2G4, Canada

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.